Novo Expands Diabetes Cell Therapy Partnership with Aspect Bio
21 Jan 2026 //
REUTERS
Novo Riffs On Apple`s `Get A Mac` Ads In New Ozempic Push
20 Jan 2026 //
FIERCE PHARMA
Novo Nordisk Launches "There`s Only One Ozempic" Campaign
20 Jan 2026 //
PR NEWSWIRE
CDMOs Pin Hopes on FDA PreCheck for New U.S. Sites
20 Jan 2026 //
BIOSPACE
Novo Holdings Buys 49% Stake In Surya Hospitals
20 Jan 2026 //
ECONOMICTIMES
Aspect Biosystems, Novo Nordisk Advance Partnership For Diabetes
20 Jan 2026 //
GLOBENEWSWIRE
SEC Recommends Three Firms For Semaglutide Formulations
19 Jan 2026 //
PHARMABIZ
Novo Boosted As Oral Wegovy Reaches 3,000 Patients In Debut Week
19 Jan 2026 //
BIOSPACE
JPM26: All Of The Meetings, None Of The Megadeals
15 Jan 2026 //
FIERCE BIOTECH
Compounder Sues Lilly, Novo, Claims Coordinated Crackdown
15 Jan 2026 //
BIOSPACE
Novo Foundation Invests $860M To Nurture Homegrown Biotechs
15 Jan 2026 //
FIERCE BIOTECH
Novo Refocuses On Diabetes & Obesity, Expanding GLP-1 Market
14 Jan 2026 //
BIOSPACE
Lilly Strategizes For Dominance In Evolving Obesity Market
14 Jan 2026 //
BIOSPACE
Strive Pharmacy Sues Eli Lilly and Novo Nordisk
14 Jan 2026 //
PR NEWSWIRE
JPM26: Novo CEO Outlines R&D, Marketing Tactics For 2026
14 Jan 2026 //
FIERCE PHARMA
Pfizer Expedites Obesity Programs Amid Patent Cliff Challenge
13 Jan 2026 //
BIOSPACE
JPM: Novo CSO Craves `Different Flavors` Of Pipeline Innovation
13 Jan 2026 //
FIERCE BIOTECH
JPM26 Day 1: Obesity Front-And-Center, Q4 Sales Beats
13 Jan 2026 //
BIOSPACE
US FDA Requests Removal of Suicide Warnings From Weight-loss Drug
13 Jan 2026 //
REUTERS
Canadian Pharma Platform To Provide Indian-Sourced Ozempic
09 Jan 2026 //
ECONOMICTIMES
Amazon Pharma Widens Wegovy Pill Access With Insurance
09 Jan 2026 //
BUSINESSWIRE
Novo Conducts Weight Stigma Conversation At NYC Commuter Hub
08 Jan 2026 //
FIERCE PHARMA
Enforcement Report - Week of January 7, 2026
07 Jan 2026 //
FDA
Saverxcanada.To Offers Ozempic From India Below U.S. Retail
07 Jan 2026 //
PR NEWSWIRE
HC Seeks Novo Nordisk`s Reply On Natco Plea To Revoke Patent
06 Jan 2026 //
ECONOMICTIMES
Ro Launches Wegovy Pill Through Integration with Novo Nordisk
05 Jan 2026 //
PR NEWSWIRE
Novo launches Wegovy pill in US from $149 per month for patients
05 Jan 2026 //
REUTERS
Novo`s GLP-1 Failure Sparks Alzheimer`s Combination Opportunity
02 Jan 2026 //
BIOSPACE
China`s Top Court Upholds Novo Nordisk Semaglutide Patent
31 Dec 2025 //
GLOBENEWSWIRE
Novo and Lilly Cut Prices of Weight-Loss Drugs in China
29 Dec 2025 //
REUTERS
Intense Rivalry Between Lilly And Novo Opens Up India
24 Dec 2025 //
ECONOMICTIMES
Novo Nordisk shares jump after US approves Wegovy pill
24 Dec 2025 //
REUTERS
Emcure Pharma Launches Second Novo Drug For Weight Management
23 Dec 2025 //
ECONOMICTIMES
FDA Approves Novo Nordisk`s Wegovy Pill For Adult Weight Loss
23 Dec 2025 //
PR NEWSWIRE
Novo Nordisk’s Wegovy Receives Approval in US
22 Dec 2025 //
FDA
Emcure Launches Poviztra Semaglutide Injection In India
22 Dec 2025 //
EXPRESSPHARMA
Novo Files Marketing Application For Next-gen Weight-Loss Drug
22 Dec 2025 //
REUTERS
Novo Gets Warning Letter At Site Formerly Owned By Catalent
17 Dec 2025 //
FIERCE PHARMA
Form Health Simplifies GLP-1 Coverage, Transparent Pricing
16 Dec 2025 //
BUSINESSWIRE
Novo`s Oral Semaglutide Is PCPs` Most-Anticipated Obesity Med
15 Dec 2025 //
FIERCE PHARMA
Delhi HC Denies Stay On Dr. Reddy`s Export Of Semaglutide
13 Dec 2025 //
ECONOMICTIMES
Novo Nordisk Brings Blockbuster Weight-Loss Drug Ozempic To India
12 Dec 2025 //
ECONOMICTIMES
Novo Nordisk: efficacious dose of Wegovy recommended by theEMA
12 Dec 2025 //
GLOBENEWSWIRE
Delhi HC OKs Sun Pharma`s Export of Proprietary Weight-Loss Drug
10 Dec 2025 //
ECONOMICTIMES
Novo Nordisk Has Completed Its Acquisition Of Akero Therapeutics
09 Dec 2025 //
GLOBENEWSWIRE
Slimmer price tag helps Wegovy sales gain weight
09 Dec 2025 //
ECONOMICTIMES
Novo Nordisk Prepares For December Ozempic Launch In India
04 Dec 2025 //
ECONOMICTIMES
Semaglutide Trials Yield Insights for Alzheimer`s Therapies
04 Dec 2025 //
PR NEWSWIRE
Novo Nordisk India, Healthify Launch AI-Enabled Patient Support
03 Dec 2025 //
ECONOMICTIMES
Lilly, Novo Pricing Strategies Set Stage For Future Competition
03 Dec 2025 //
BIOSPACE
HC OKs Dr. Reddy`s Semaglutide Exports, Bars Sales in India
03 Dec 2025 //
ECONOMICTIMES
Biotechs Secure Fill/Finish Capacity Amid Novo Site Scrutiny
02 Dec 2025 //
BIOSPACE
Novo Nordisk Justifies Reasoning Behind Failed GLP-1 Alzheimer
02 Dec 2025 //
REUTERS
Omeros Closes Deal With Novo Nordisk For MASP-3 Inhibitor OMS906
01 Dec 2025 //
BUSINESSWIRE
Novo Nordisk Cuts Wegovy Prices, Generic Firms Adjust Pricing
27 Nov 2025 //
ECONOMICTIMES
Novo Nordisk Seeks FDA Approval for Higher 7.2mg Wegovy Dose
26 Nov 2025 //
PR NEWSWIRE
Novo Expands Pivotal Program After Amycretin Shines in Diabetes
25 Nov 2025 //
GLOBENEWSWIRE
Novo Reports 2 Trial Failures For GLP-1 In Alzheimer`s Disease
24 Nov 2025 //
GLOBENEWSWIRE
Biogen`s Leqembi Rises After Novo GLP-1 Fails In Alzheimer
24 Nov 2025 //
BIOSPACE
Semaglutide Compounder Drops Claims After Novo Nordisk Challenge
21 Nov 2025 //
FIERCE PHARMA

Market Place
Sourcing Support